6/29/2019 Proton Pump Inhibitors (PPIs) Market Worth USD 3.

24 Billion, at 4% CAGR During 2019-2023 | Technavio - Bloomberg

Business

Proton Pump Inhibitors (PPIs) Market Worth

USD 3.24 Billion, at 4% CAGR During 2019-
2023 | Technavio
June 25, 2019, 6:30 PM GMT+6

Proton Pump Inhibitors (PPIs) Market Worth USD 3.24 Billion, at 4% CAGR
During 2019-2023 | Technavio

Business Wire

LONDON -- June 25, 2019

According to Technavio Research Report "Proton Pump Inhibitors (PPIs) Market

by product (OTC PPIs and prescription PPIs) and geographical regions (North
America, Europe, Asia and ROW) is witnessed to grow by USD 3.24 billion, at a
CAGR of 4% from 2019 to 2023”.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20190625005509/en/

Technavio has published a new market research report on the global proton pump
inhibitors (PPIs) market from 2019-2023. (Graphic: Business Wire)

Technavio has published a new market research report on the global proton pump
inhibitors (PPIs) market from 2019-2023. (Graphic: Business Wire)

Free sample report contains market size and forecast, drivers, challenges,
trends, and more – Request for Sample @

https://www.technavio.com/talk-to-us?
report=Proton%20Pump%20Inhibitors%20(PPIs)%20Market%20by%20Product%20and%20Geography%20-
%20Global%20Forecast%20and%20Analysis%202019-2023&type=sample&src=report

Global Proton Pump Inhibitors (PPIS) Market: Rising prevalence of obesity

In recent times, an increase in GERD symptoms was observed in individuals who

are overweight but continue to have a basal metabolic index (BMI) in normal
ranges. Considering the rising cases of obesity, the medical cost of obesity
is anticipated to increase heavily. Obesity is among the leading causes of
various chronic diseases, which include cardiovascular diseases, type 2
diabetes, and certain types of cancer, resulting in premature death. In
addition, there is an increasing trend of childhood obesity among children and
adolescents, thus presenting an increased risk of poor health in these
population sub-groups. Consequently, the rising prevalence of obesity
increases the risk of being affected with esophageal and
gastrointestinal-related diseases, which is anticipated to increase the demand
for PPIs.

“Apart from the rising prevalence of obesity, the growing geriatric population
is another major factor that is expected to boost market growth. Old age
increases the risk of being affected by gastrointestinal problems and related
comorbidities, which, in turn, will ensure continuous demand for PPIs", says a
senior analyst at Technavio.
https://www.bloomberg.com/press-releases/2019-06-25/proton-pump-inhibitors-ppis-market-worth-usd-3-24-billion-at-4-cagr-during-2019-2023-technavio 1/3
6/29/2019 Proton Pump Inhibitors (PPIs) Market Worth USD 3.24 Billion, at 4% CAGR During 2019-2023 | Technavio - Bloomberg

Global Proton Pump Inhibitors (PPIS) Market: Segmentation analysis

This market research report segments the global proton pump inhibitors (PPIs)
market by product (OTC PPIs and prescription PPIs) and geographical regions
(North America, Europe, Asia and ROW).

The North American region led the market in 2018, followed by Europe, Asia and
ROW respectively. During the forecast period, the North American region is
expected to maintain its dominance over the PPI market and register the
highest incremental growth due to the presence of large pharmaceutical
companies that offer both branded and generic PPIs. Moreover, the presence of
a proper regulatory framework for the approval of new drugs in the region is
helping the growth of the market in this region.

Speak to Research Expert @

https://www.technavio.com/talk-to-us?
report=Proton%20Pump%20Inhibitors%20(PPIs)%20Market%20by%20Product%20and%20Geography%20-
%20Global%20Forecast%20and%20Analysis%202019-2023&type=customization

Global Proton Pump Inhibitors (PPIS) Market: Reformulation of drugs

A key factor driving the growth of the market is the reformulation of drugs.
Drug delivery systems such as transdermal patches, extended release (ER)
formulations, and orally disintegrating tablets increase the efficacy of drugs
either by increasing patient compliance or by increasing the bioavailability
of the drug. Therefore, the reformulation of marketed drugs provides an
opportunity to grab patent term extensions, which can delay the entry of
generic versions into the market. Reformulation of solid dosage forms, such as
tablets, can provide a window for titrating the dose as per the individual
requirements. In addition, the reformulation of drugs helps vendors in
maintaining their position in the global proton pump inhibitors (PPIs) market.

Few Major Players for the Proton Pump Inhibitors (PPIs) Market are:

* AstraZeneca Plc
* Bayer AG
* Johnson & Johnson Services Inc.
* Pfizer Inc.
* Takeda Pharmaceutical Co. Ltd.

Browse Industries Reports @ Pharmaceuticals

About Technavio

Technavio is a leading global technology research and advisory company. Their

research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of

more than 10,000 reports and counting, covering 800 technologies, spanning
across 50 countries. Their client base consists of enterprises of all sizes,
including more than 100 Fortune 500 companies. This growing client base relies
on Technavio’s comprehensive coverage, extensive research, and actionable
market insights to identify opportunities in existing and potential markets
and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at
media@technavio.com.

View source version on businesswire.com:

https://www.businesswire.com/news/home/20190625005509/en/

https://www.bloomberg.com/press-releases/2019-06-25/proton-pump-inhibitors-ppis-market-worth-usd-3-24-billion-at-4-cagr-during-2019-2023-technavio 2/3
6/29/2019 Proton Pump Inhibitors (PPIs) Market Worth USD 3.24 Billion, at 4% CAGR During 2019-2023 | Technavio - Bloomberg
Contact:

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com

Terms of Service
Trademarks Privacy Policy
©2019 Bloomberg L.P. All Rights Reserved
Careers Made in NYC Advertise Ad Choices Contact Us Help

https://www.bloomberg.com/press-releases/2019-06-25/proton-pump-inhibitors-ppis-market-worth-usd-3-24-billion-at-4-cagr-during-2019-2023-technavio 3/3